Media Resources

Every day, hundreds of thousands of scientists across the globe use Life Technologies’ products and services to advance science in fields as diverse as personalized medicine, 21st century forensics, and biofuels. Here is contact information for members of the media to use for more information about how our company and products are used to innovate in science.

Media Contacts

Farnaz Khadem

Life Technologies
Head of Corporate Communications and Public Relations
P (760) 603-7245

Mark Springer

Life Technologies
Technical Public Relations,
Molecular Biology
P (650) 638-6113

Tim Ingersoll

Life Technologies
Corporate Media Relations
P (760) 918-3883

Lauren Lum

Life Technologies
Technical Public Relations,
Cell Systems Division, Applied Markets
P (650) 638-6916

Kim Evans

Life Technologies
Corporate Communications | Social Media
P (760) 476-7816

Patty Zamora

Life Technologies
Technical Public Relations,
Genomics, DNA Sequencing
P (760) 476-7818

Eriko Takahata

Life Technologies
Communications, Japan

Vivian Lv

Life Technologies
Communications, Asia Pacific

News

  • SOLiD 4 Announced

    Company announces SOLiD(TM) 4 System, delivering industry's most cost effective, highest quality genome for $6,000, reduced to $3,000 by end of 2010 with SOLiD(TM) 4hq upgrade.

    Read All Close
  • LT & Ignite Institute

    Life Technologies and the Ignite Institute for Individualized Health for a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia. Ignite will acquire 100 of the Applied Biosystems SOLiD(TM) 4 Systems, the most advanced next generation DNA sequencing platform on the market, establishing the largest concentration of genetic analytical power in North America.

    Read All Close
  • Q4 & FY09 Results

    Life Technologies today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

    Read All Close

Life (Common Stock)